Sphera Funds Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.63M	Sell	247,961 -159,748	-39%	-$2.55M	0.62%	60
2025 Q4	$3.14M	Hold	407,709	–	–	0.66%	60
2025 Q3	$3M	Buy	407,709 +224,615	+123%	+$1.15M	0.71%	53
2025 Q2	$732K	Sell	183,094 -22,765	-11%	-$82.8K	0.19%	94
2025 Q1	$655K	Sell	205,859 -294,632	-59%	-$1.39M	0.16%	99
2024 Q4	$2.68M	Buy	+500,491	New	+$3.74M	0.49%	67
2019 Q2	–	Sell	-83,607	Closed	-$336K	–	95
2019 Q1	$336K	Sell	83,607 -237,823	-74%	-$1M	0.05%	101
2018 Q4	$1.18M	Hold	321,430	–	–	0.17%	88
2018 Q3	$2.76M	Sell	321,430 -14,557	-4%	-$146K	0.36%	78
2018 Q2	$3.69M	Buy	335,987 +14,557	+5%	+$162K	0.59%	59
2018 Q1	$3.71M	Buy	321,430 +100,000	+45%	+$946K	0.65%	52
2017 Q4	$2.29M	Hold	221,430	–	–	0.37%	84
2017 Q3	$3.53M	Sell	221,430 -36,235	-14%	-$501K	0.63%	55
2017 Q2	$3.12M	Sell	257,665 -21,501	-8%	-$230K	0.64%	55
2017 Q1	$5.8M	Sell	279,166 -41,063	-13%	-$643K	1.48%	21
2016 Q4	$4.58M	Sell	320,229 -4,824	-1%	-$73.4K	1.41%	20
2016 Q3	$5.35M	Hold	325,053	–	–	1.23%	25
2016 Q2	$4.58M	Buy	325,053 +214,132	+193%	+$2.89M	1.28%	22
2016 Q1	$1.61M	Buy	+110,921	New	+$1.59M	0.43%	66